Rituximab Combined with Steroid and Tacrolimus Treats Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Case Report and Review of the Literature
- Authors: Liu D.1, Xia M.1, Wang C.1, Zhu X.1, Chen G.1, Liu H.1
-
Affiliations:
- Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
- Issue: Vol 31, No 41 (2024)
- Pages: 6902-6908
- Section: Anti-Infectives and Infectious Diseases
- URL: https://hum-ecol.ru/0929-8673/article/view/645147
- DOI: https://doi.org/10.2174/0109298673272183240108093135
- ID: 645147
Cite item
Full Text
Abstract
Introduction:Due to the confounding heterogeneity, the therapeutic strategy for proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) remains to be defined.
Case Representation:We report a 38-year-old man with recurrent swelling of the eyelids and lower limbs, undergoing rituximab combined with steroid and tacrolimus treatment, who achieved an improved renal outcome. Underlying solid malignant tumours were excluded from the diagnosis.
Discussion:We treated patients with rituximab along with steroids and tacrolimus. Improvements in proteinuria and renal function were observed. We also reviewed the current literature to assess the efficacy of rituximab in the treatment of PGNMID.
Conclusion:However, a larger pool of patients and a longer follow-up period are required to establish the role of rituximab and steroids in the treatment of PGNMID.
About the authors
Di Liu
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Email: info@benthamscience.net
Ming Xia
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Email: info@benthamscience.net
Chang Wang
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Email: info@benthamscience.net
Xuejing Zhu
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Email: info@benthamscience.net
Guochun Chen
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Email: info@benthamscience.net
Hong Liu
Hunan Key Laboratory of Kidney Disease and Blood Purification, Department of Nephrology, The Second Xiangya Hospital of Central South University
Author for correspondence.
Email: info@benthamscience.net
References
- Nasr, S.H.; Markowitz, G.S.; Stokes, M.B.; Seshan, S.V.; Valderrama, E.; Appel, G.B.; Aucouturier, P.; DAgati, V.D. Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney Int., 2004, 65(1), 85-96. doi: 10.1111/j.1523-1755.2004.00365.x PMID: 14675039
- Nasr, S.H.; Satoskar, A.; Markowitz, G.S.; Valeri, A.M.; Appel, G.B.; Stokes, M.B.; Nadasdy, T.; DAgati, V.D. Proliferative glomerulonephritis with monoclonal IgG deposits. J. Am. Soc. Nephrol., 2009, 20(9), 2055-2064. doi: 10.1681/ASN.2009010110 PMID: 19470674
- Nada, R.; Gowda, K.K.; Ramachandran, R.; Joshi, K.; Tewari, R.; Kohli, H.S.; Jha, V.; Gupta, K.L. Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains. Indian J. Nephrol., 2015, 25(6), 344-348. doi: 10.4103/0971-4065.151354 PMID: 26664209
- Bridoux, F.; Javaugue, V.; Nasr, S.H.; Leung, N. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: A nephrologist perspective. Nephrol. Dial. Transplant., 2021, 36(2), 208-215. doi: 10.1093/ndt/gfz176 PMID: 33494099
- Aucouturier, P.; DAgati, V.D.; Ronco, P. A fresh perspective on monoclonal gammopathies of renal significance. Kidney Int. Rep., 2021, 6(8), 2059-2065. doi: 10.1016/j.ekir.2021.04.026 PMID: 34386655
- Barbour, S.J.; Beaulieu, M.C.; Zalunardo, N.Y.; Magil, A.B. Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases. Nephrol. Dial. Transplant., 2011, 26(8), 2712-2714. doi: 10.1093/ndt/gfr251 PMID: 21633102
- Nasr, S.H.; Sethi, S.; Cornell, L.D.; Fidler, M.E.; Boelkins, M.; Fervenza, F.C.; Cosio, F.G.; DAgati, V.D. Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin. J. Am. Soc. Nephrol., 2011, 6(1), 122-132. doi: 10.2215/CJN.05750710 PMID: 20876681
- Tsuji, T; Miura, M; Yanai, M De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1kappa subtype in a kidney allograft. Nephrology, 2016, 21(S1), 44-47.
- Merhi, B.; Patel, N.; Bayliss, G.; Henriksen, K.J.; Gohh, R. Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab. Clin. Kidney J., 2017, 10(3), 405-410. doi: 10.1093/ckj/sfx001 PMID: 28616219
- Torrealba, J.; Gattineni, J.; Hendricks, A.R. Proliferative glomerulonephritis with monoclonal immunoglobulin G lambda deposits: Report of the first pediatric case. Case Rep. Nephrol. Dial., 2018, 8(1), 70-75. doi: 10.1159/000488641 PMID: 29850460
- Xing, G.; Gillespie, R.; Bedri, B.; Quan, A.; Zhang, P.; Zhou, X.J. Proliferative glomerulonephritis with monoclonal IgG deposits in children and young adults. Pediatr. Nephrol., 2018, 33(9), 1531-1538. doi: 10.1007/s00467-018-3949-8 PMID: 29616329
- Maan, D.; Clark, B.; Bunker, M.; Arora, S. Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy. BMJ Case Rep., 2018, 11(1), e225205. doi: 10.1136/bcr-2018-225205 PMID: 30567197
- Wen, J.; Wang, W.; Xu, F.; Chen, J.; Zhang, M.; Cheng, D.; Ni, X.; Li, X.; Liu, Z. Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts. BMC Nephrol., 2018, 19(1), 173. doi: 10.1186/s12882-018-0969-3 PMID: 29996809
- Gumber, R.; Cohen, J.B.; Palmer, M.B.; Kobrin, S.M.; Vogl, D.T.; Wasserstein, A.G.; Nasta, S.D.; Bleicher, M.B.; Bloom, R.D.; Dember, L.; Cohen, A.; Weiss, B.M.; Hogan, J.J. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int., 2018, 94(1), 199-205. doi: 10.1016/j.kint.2018.02.020 PMID: 29759418
- Sawada, A; Kawanishi, K; Horita, S Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Nephrology, 2016, 21(S1), 48-52.
- Buxeda, A.; Said, S.M.; Nasr, S.H.; Leung, N.; El Ters, M.; Cosio, F.G. Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin deposits in kidney allografts treated with anti-CD20 antibodies. Transplantation, 2019, 103(7), 1477-1485. doi: 10.1097/TP.0000000000002577 PMID: 30747850
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int., 2021, 100(4S), S1-S276. PMID: 34556256
- Li, Y.; Fu, R.; Gao, J.; Wang, L.; Duan, Z.; Tian, L.; Ge, H.; Ma, X.; Zhang, Y.; Li, K.; Xu, P.; Tian, X.; Chen, Z. Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: A 18-month prospective clinical trial. Sci. Rep., 2022, 12(1), 255. doi: 10.1038/s41598-021-03691-0 PMID: 34996948
- Zhao, J.; Ma, F.; Bai, M.; Sun, S. Low-dose corticosteroid combined with mycophenolate mofetil for IgA Nephropathy with stage 3 or 4 CKD: A retrospective cohort study. Clin. Ther., 2021, 43(5), 859-870. doi: 10.1016/j.clinthera.2021.03.009 PMID: 33863547
- Shengyou, Y.; Li, Y.; Zhihong, H.; Yuanyuan, M. Influence of tacrolimus on podocyte injury inducted by angiotensin II. J. Renin Angiotensin Aldosterone Syst., 2015, 16(2), 260-266. doi: 10.1177/1470320314568520 PMID: 25650384
- Zhang, S.; Wang, H.; Liu, Y.; Yang, W.; Liu, J.; Han, Y.; Liu, Y.; Liu, F.; Sun, L.; Xiao, L. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway. J. Cell. Mol. Med., 2020, 24(17), 9810-9824. doi: 10.1111/jcmm.15562 PMID: 32779844
- Ma, R; Wang, Y; Xu, Y. Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy. J. Diabetes. Res, 2021, 8832114. PMID: 34095318 PMCID: PMC8163546
Supplementary files
